SULFONAMID-DERIVATE ZUR BEHANDLUNG VON DIABETES
European patent · EP1663193 · Deleted
Register entry
- Publication number
- EP1663193
- Application number
- EP04787131
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Sep 13, 2004
- Published
- Jun 7, 2006
- Granted
- Apr 4, 2012
- Deleted
- Sep 30, 2016
- Reason
- Annual fee unpaid
- IPC classes
- A61K 31/18 (2006.01)A61K 31/4535 (2006.01)A61P 3/10 (2006.01)
- Priority
- EP 03102742 12.09.2003
- PCT application
- PCT/EP2004/052143 13.09.2004
- PCT publication
- WO2005/025558 24.03.2005
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 19, 2017
Deleted, fee unpaid
Published in Swissreg on 19.04.2017
- Jul 4, 2014
Address changed
- Representative
- Merck Serono S.A., Intellectual Property Department, Centre Industriel, 1267 Coinsins → Merck Serono S.A., Intellectual Property, Zone Industrielle de l'Ouriettaz, 1170 Aubonne
Published in Swissreg on 04.07.2014
- May 8, 2013
Address changed
- Representative
- Merck Serono S.A. - Geneva, IP Department, 9, chemin des Mines, 1202 Geneva → Merck Serono S.A., Intellectual Property Department, Centre Industriel, 1267 Coinsins
Published in Swissreg on 08.05.2013
- May 1, 2012
Agent entered
- Representative
- Merck Serono S.A. - Geneva, IP Department, 9, chemin des Mines, 1202 Geneva
Published in Swissreg on 01.05.2012
- Apr 4, 2012
Granted
Published in Swissreg on 04.04.2012
Parties
Inventor
RUECKLE, Thomas
CH-1228 Plan-les-Ouates
VITTE, Pierre-Alain
F-74380 Cranves-Sales, FR
GOTTELAND, Jean-Pierre
F-74160 Beaumont, FR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.